Zobrazeno 1 - 10
of 372
pro vyhledávání: '"Peter B, Jahrling"'
Autor:
Teressa M. Shaw, Samuel T. Dettle, Andres Mejia, Jennifer M. Hayes, Heather A. Simmons, Puja Basu, Jens H. Kuhn, Mitchell D. Ramuta, Cody J. Warren, Peter B. Jahrling, David H. O’Connor, Liupei Huang, Misbah Zaeem, Jiwon Seo, Igor I. Slukvin, Matthew E. Brown, Adam L. Bailey
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 4, Pp 721-731 (2024)
Genetically diverse simian arteriviruses (simarteriviruses) naturally infect geographically and phylogenetically diverse monkeys, and cross-species transmission and emergence are of considerable concern. Characterization of most simarteriviruses beyo
Externí odkaz:
https://doaj.org/article/1a1dc35e15b7408f96c81ee61028b57e
Autor:
Jennifer Sword, Ji Hyun Lee, Marcelo A. Castro, Jeffrey Solomon, Nina Aiosa, Syed M. S. Reza, Winston T. Chu, Joshua C. Johnson, Christopher Bartos, Kurt Cooper, Peter B. Jahrling, Reed F. Johnson, Claudia Calcagno, Ian Crozier, Jens H. Kuhn, Lisa E. Hensley, Irwin M. Feuerstein, Venkatesh Mani
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Marburg virus (MARV) is a highly virulent zoonotic filovirid that causes Marburg virus disease (MVD) in humans. The pathogenesis of MVD remains poorly understood, partially due to the low number of cases that can be studied, the absence of s
Externí odkaz:
https://doaj.org/article/56c1f92e128642cca1baf58ff48cf89f
Autor:
Tiago Abreu-Mota, Katie R. Hagen, Kurt Cooper, Peter B. Jahrling, Gene Tan, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
There is currently no approved vaccine for Lassa fever virus (LASV). Here, Abreu-Mota et al. develop an inactivated, adjuvanted vaccine candidate expressing LASV glycoprotein (GPC) in a rabies virus vector, and show that non-neutralizing LASV GPC-spe
Externí odkaz:
https://doaj.org/article/515d6b50b90b48d2976fee557e117292
Autor:
Manasi Tamhankar, Dawn M. Gerhardt, Richard S. Bennett, Nicole Murphy, Peter B. Jahrling, Jean L. Patterson
Publikováno v:
Virology Journal, Vol 15, Iss 1, Pp 1-12 (2018)
Abstract Background Currently, no FDA-approved vaccines or treatments are available for Ebola virus disease (EVD), and therapy remains largely supportive. Ebola virus (EBOV) has broad tissue tropism and can infect a variety of cells including epithel
Externí odkaz:
https://doaj.org/article/c18d663e89c4459eb2269f7b17fcd15e
Autor:
Timothy K. Cooper, Louis Huzella, Joshua C. Johnson, Oscar Rojas, Sri Yellayi, Mei G. Sun, Sina Bavari, Amanda Bonilla, Randy Hart, Peter B. Jahrling, Jens H. Kuhn, Xiankun Zeng
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
Abstract Survivors of Ebola virus infection may become subclinically infected, but whether animal models recapitulate this complication is unclear. Using histology in combination with immunohistochemistry and in situ hybridization in a retrospective
Externí odkaz:
https://doaj.org/article/948a329586ed44359c28050be99073b3
Autor:
Reed F. Johnson, Lauren A. Keith, Timothy K. Cooper, Srikanth Yellayi, Nicole M. Josleyn, Krisztina B. Janosko, James D. Pettitt, David Thomasson, Katie R. Hagen, Robin Gross, John G. Bernbaum, Debbie Douglas, Jeffrey Solomon, Mark Martinez, Kurt Cooper, Marisa St. Claire, Danny R. Ragland, Peter B. Jahrling, Jens H. Kuhn, Andrew E. Arai
Publikováno v:
Viruses, Vol 13, Iss 8, p 1571 (2021)
Hemorrhagic smallpox, caused by variola virus (VARV), was a rare but nearly 100% lethal human disease manifestation. Hemorrhagic smallpox is frequently characterized by secondary bacterial infection, coagulopathy, and myocardial and subendocardial he
Externí odkaz:
https://doaj.org/article/529da320d14a4600a4622666dfa585c4
Autor:
Pramila Walpita, Yu Cong, Peter B. Jahrling, Oscar Rojas, Elena Postnikova, Shuiqing Yu, Lisa Johns, Michael. R. Holbrook
Publikováno v:
npj Vaccines, Vol 2, Iss 1, Pp 1-9 (2017)
Nipah virus: Virus-like particles protect against major public health concern A vaccine candidate consisting of virus-like particles could offer the first effective prophylaxis against the deadly Nipah virus. Endemic to Malaysia, Bangladesh, and Indi
Externí odkaz:
https://doaj.org/article/c73ddbefeb8a401ca3556c3aba293d75
Autor:
Anna N. Honko, Joshua C. Johnson, Jonathan S. Marchand, Louis Huzella, Ricky D. Adams, Nicholas Oberlander, Lisa M. Torzewski, Richard S. Bennett, Lisa E. Hensley, Peter B. Jahrling, Gene G. Olinger
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract The recent epidemic of Ebola virus disease in West Africa resulted in an unprecedented number of cases and deaths. Due to the scope of the outbreak combined with the lack of available approved treatment options, there was strong motivation t
Externí odkaz:
https://doaj.org/article/3c4b86005dec400d8fd8007eea1d844b
Autor:
Evelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, Steven R King, Derek Dube, Maureen Legendre, Elizabeth Nelson, Kelly C Drews, Robin Gross, Dawn M Gerhardt, Lisa Torzewski, Elena Postnikova, Janie Y Liang, Bhupal Ban, Jagathpala Shetty, Lisa E Hensley, Peter B Jahrling, Gene G Olinger, Judith M White, David M Markovitz
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 7, p e0007595 (2019)
Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, es
Externí odkaz:
https://doaj.org/article/be3daa2799a548df9e5ee6400d5ad727
Autor:
Abigail Lara, Yu Cong, Peter B Jahrling, Mark Mednikov, Elena Postnikova, Shuiqing Yu, Vincent Munster, Michael R Holbrook
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 6, p e0007454 (2019)
The ability to appropriately mimic human disease is critical for using animal models as a tool for understanding virus pathogenesis. In the case of Nipah virus (NiV), infection of humans appears to occur either through inhalation, contact with or con
Externí odkaz:
https://doaj.org/article/e741d0a4a0f1432cab7b7947013a3b4f